← Open Payments lookup

IKECHI NNAWUCHI: Open Payments

NPI 1598798662 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$98,496 in 260 payments from 12 companies in 2025. Trend: 2023 $84,091 · 2024 $63,718 · 2025 $98,496

Speaker / faculty: $78,628Consulting: $7,600Food & beverage: $6,516Travel & lodging: $5,752
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.52$45,745
Neurocrine BioSciences, Inc.46$41,614
ABBVIE INC.22$7,518
E.R. Squibb & Sons, L.L.C.35$823
Vanda Pharmaceuticals Inc.20$736
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)26$673
Teva Pharmaceuticals USA, Inc.18$388
Lundbeck LLC20$383
Alkermes, Inc.15$296
Janssen Scientific Affairs, LLC1$149

Products named: INGREZZA, ABILIFY MAINTENA, REXULTI, VRAYLAR, COBENFY, CAPLYTA, FANAPT, ABILIFY ASIMTUFII.

Industry payments across DC — which companies pay providers there.